Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Paclitaxel in Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT01287624. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-
ClinicalTrials.gov study NCT02819518. IPD Sharing: YES. Countries: 0. Publications: 3.
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
ClinicalTrials.gov study NCT02302742. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
ClinicalTrials.gov study NCT03756298. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Huaier Granule in Treating Women With Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02615457. IPD Sharing: Not stated. Countries: 1. Publications: 7.
A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoad
ClinicalTrials.gov study NCT05629585. IPD Sharing: YES. Countries: 17. Publications: 1.
CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05081492. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Allogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast Cancer
ClinicalTrials.gov study NCT01375023. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast Cancer
ClinicalTrials.gov study NCT00691379. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer
ClinicalTrials.gov study NCT03150576. IPD Sharing: YES. Countries: 1. Publications: 3.
Study of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT01045304. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START)
ClinicalTrials.gov study NCT05035745. IPD Sharing: NO. Countries: 1. Publications: 2.
Study of Single Agent Pembrolizumab (MK-3475) Versus Single Agent Chemotherapy for Metastatic Triple Negative Breast Cancer (MK-3475-119/KEYNOTE-119)
ClinicalTrials.gov study NCT02555657. IPD Sharing: YES. Countries: 0. Publications: 4.
Docetaxel+Carboplatin vs Epirubicin+Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment in Triple-negative Breast Cancer
ClinicalTrials.gov study NCT01150513. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients
ClinicalTrials.gov study NCT01372579. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1
ClinicalTrials.gov study NCT02620280. IPD Sharing: Not stated. Countries: 7. Publications: 2.
Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT01057069. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Albumin-Bound Paclitaxel Followed by Epirubicin in Combination With Cyclophosphamide in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03799679. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Combination Study of Rucaparib and Atezolizumab in Participants With Advanced Gynecologic Cancers and Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT03101280. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Study of Apatinib in Metastatic Triple-Negative Breast Cancer Patients
ClinicalTrials.gov study NCT01176669. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.